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We describe a high throughput method for screening up to 1728 distinct chemicals with protein crystals
on a single microplate. Acoustic droplet ejection (ADE) was used to co-position 2.5 nL of protein, precip-
itant, and chemicals on a MiTeGen in situ-1 crystallization plate™ for screening by co-crystallization or
soaking. ADE-transferred droplets follow a precise trajectory which allows all components to be trans-
ferred through small apertures in the microplate lid. The apertures were large enough for 2.5 nL droplets
to pass through them, but small enough so that they did not disrupt the internal environment created by
the mother liquor. Using this system, thermolysin and trypsin crystals were efﬁciently screened for bind-
ing to a heavy-metal mini-library. Fluorescence and X-ray diffraction were used to conﬁrm that each
chemical in the heavy-metal library was correctly paired with the intended protein crystal. A fragment
mini-library was screened to observe two known lysozyme ligands using both co-crystallization and
soaking. A similar approach was used to identify multiple, novel thaumatin binding sites for ascorbic acid.
This technology pushes towards a faster, automated, and more ﬂexible strategy for high throughput
screening of chemical libraries (such as fragment libraries) using as little as 2.5 nL of each component.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under theCCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
High throughput screening using X-ray crystallography is a
powerful tool for applications such as fragment library screening
(for structure-based drug discovery) and additive library screening
(for improving crystal quality) (Spurlino, 2011). For structure-based
drug discovery projects (Blundell et al., 2002) the screened library
may consist of individual fragments (Chilingaryan et al., 2012) or
pooled fragments (Nicholls et al., 2010). For crystal quality
improvement projects the screened library may contain additives
such as protic ionic liquids (Kennedy et al., 2011). The chemicals
being screened can be added either before crystal formation(co-crystallization) or after the crystals have grown (soaking).
With either method, the objective is to screen a library which
may consist of several thousand chemicals using a minimum
amount of puriﬁed protein, screened chemicals, and other
consumables.
Acoustic droplet ejection (ADE) has a demonstrated utility for
growing protein crystals (Villasenor et al., 2012), improving the
quality of protein crystals (Villasenor et al., 2010), mounting pro-
tein crystals onto data collection media (Soares et al., 2011;
Roessler et al., 2013), and for high throughput screening of protein
crystals (Yin et al., 2014). ADE uses a sound pulse (Fig. 1) to propel
a liquid or suspended solid out of a source location, through a short
air column, and onto an arbitrary destination (Ellson et al., 2003;
volume accuracy 5%, trajectory precision 1.3). The high trajectory
precision enables ‘‘drop on drop’’ combination of distinct compo-
nents from different source wells onto the same destination
Fig. 1. Acoustic droplet ejection. ADE uses sound energy to transfer variable micro-
droplets (e.g. nanoliter or picoliter) of solution (protein, precipitant, chemicals, etc.)
from a well in a source plate through a short air column (1 cm) to data collection
media. Sound wave energy from the transducer is channeled to the focal point (i.e.
ejection zone) displacing the surface where a controlled ejection occurs. Droplet
size is governed by the wavelength of the sound emitted. In this work an Echo 550
was used to combine proteins, precipitants, and chemicals for co-crystallization and
soaking experiments in 1728 distinct locations on a MiTeGen in situ crystallization
plate. The Echo 550 does not use frequency changes to transfer different volumes.
Instead, it uses a ﬁxed frequency sound pulse to transfer each component in 2.5 nL
increments.
2 DMSO is widely used as a solvent for chemical libraries because it is polar (with
properties similar to water) but it is aprotic (which extends the useful life of the
chemicals in the library). However, DMSO is a protein denaturant that is poorly
tolerated by many crystals (Arakawa et al., 2007). It is often desirable to remove the
DMSO immediately before each chemical is combined with proteins. In our
experiments DMSO could be removed by allowing the DMSO solvent to evaporate
before the protein and precipitant were added (on top of the dry residue containing
the chemical). Of course, this approach is only practical when screening non-volatile
chemicals.
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of commercially available crystallization conditions and
cryo-protectants (Cuttitta et al., 2015). The Echo 550 acoustic liq-
uid handler used in this study (Labcyte Inc., Sunnyvale, CA) trans-
fers liquids using increments of 2.5 nL (ejection velocity 1 m/s).
Villasenor and co-authors have suggested that acoustic meth-
ods might be used for structure-based drug discovery by
co-crystallizing protein and fragments using a shared reservoir
on a conventional crystallization plate (Villasenor et al., 2012,
899–6). Note that this strategy employs the same precipitant to
drive crystallization in all 96 wells of the crystallization micro-
plate. Acoustic methods are an attractive choice for
micro-crystallization for several reasons. ADE is an automated
technique that does not rely on operator skill. It is physically gentle
with no tips or tubes that may leach chemicals, cause
cross-contamination between specimens (McDonald et al., 2008),
or damage crystals. Transfers have high accuracy even at very
low volume (2.5 nL) with zero per transfer ‘‘lost volume’’ since
there are no tips or tubes that liquids can adhere to. The inaccessi-
ble ‘‘dead volume’’ at the bottom of each well is very small (4 lL;
Harris et al., 2008) and can be reduced even further (Cuttitta
et al., 2015). Specimen transfer is fast (500 mounts per second
between ﬁxed locations; 2.33 ± 0.04 mounts per second to multiple
destinations, data not shown), which reduces specimen prepara-
tion time. Our system for room temperature fragment library
screening is keyboard controlled and remote compatible, and can
be readily mastered by new users.As the working volume for crystallization drops below 50 nL,
dehydration becomes the foremost challenge. Our group made a
previous attempt to develop the on-plate high throughput screen-
ing technology proposed by Villasenor et al. in 2012 without suc-
cess (and we know of other similar attempts by other groups
from personal communications). We tried several strategies for
mitigating the impact of dehydration, such as working at 4 C,
parsing big jobs into small pieces, or simply working faster. None
of these mitigation strategies were sufﬁcient when dealing with
2.5 nL working volumes. To reduce dehydration we transferred
all protein, precipitant and fragment components through small
apertures in a plate lid that covered the MiTeGen in situ-1 crystal-
lization plate™ (Zipper et al., 2014). The MiTeGen plate was
allowed to equilibrate with the precipitant before the crystalliza-
tion ﬂuids were ejected onto it (Fig. 2). A separately designed cus-
tom plate lid was used to cover the source plate (that contained the
mini-libraries) to prevent the dimethyl sulfoxide (DMSO) that was
solvating the chemicals from swelling with incorporated water
when exposed to atmospheric humidity.
Here we describe a high throughput technique for screening
protein crystals against a chemical library, using ADE to prepare
co-crystallization or soaking experiments on MiTeGen crystalliza-
tion microplates (Fig. 3). A critical advantage of ADE is that it can
deposit solutions at their intended destination with a very high
positional accuracy. The capability to combine protein, precipitant,
and screened chemicals at 1728 distinct locations on a MiTeGen
crystallization microplate is one advantage of this positional accu-
racy that we have already mentioned. Since the precise location of
each of these 1728 experiments is known, there is also the oppor-
tunity to automate the data acquisition process by programming
the plate-handling system (such as the G-rob system used in this
work) to rapidly move between the 1728 known specimen loca-
tions. In situ data can then be obtained under computer control
so that high throughput screening can occur without operator
assistance. The speed and automation of this data acquisition
approach could facilitate structure-based, high throughput frag-
ment screening without grouping chemicals into cocktails. This
mitigates the harmful effects of a high aggregate fragment concen-
tration on protein stability and crystallization (Boyd and de Kloe,
2010; Baurin et al., 2004), prevents inter-fragment interactions
(Drinkwater et al., 2010; Nair et al., 2012), and avoids the need
to de-convolute the fragments in each cocktail after a hit
(Nicholls et al., 2010).
2. Methods
We used two techniques for high throughput screening of pro-
teins against chemical libraries, using X-ray crystallography as the
primary screening tool:
Co-crystallization of protein with a library of chemicals:
DMSO-solvated libraries were co-crystallized with protein and
screened in situ (Fig. 4A). The library chemicals were acoustically
deposited on the crystallization plate before any other components
were added, and the DMSO was allowed to evaporate (leaving the
dry residue of the chemical)2. The reservoir was then ﬁlled with
mother liquor and the crystallization plate was sealed with a custom
fabricated plate lid (Fig. 2) (Zipper et al., 2014). Once the
Fig. 2. Very small volumes of protein and chemicals can be used if all components
are added through small apertures in otherwise-sealed containers. Thermolysin
protein and chemicals were acoustically transferred to the crystallization plate (A)
through apertures in the plate lid (B) to prevent the small volumes from drying
(except for the DMSO that solvates library chemicals, which can be allowed to dry
in a co-crystallization experiment). This prevents evaporation of the specimen
(typically 2.5 nL of protein and chemical) while still allowing a high density of
distinct experiments to share each crystallization well. MiTeGen crystallization
plates, shown with the plate lid removed (C) and with the plate lid in place (D), can
accommodate 3 rows and 6 columns of distinct co-crystallization or soaking
screening experiments (18 screens per well and 96 wells make 1728 total screens
per plate). Crystals can be seen through the apertures in the close up (E).
Fig. 3. Using acoustic droplet ejection (ADE) to screen 1728 chemicals on one MiTeGen
droplets of protein, precipitant, or chemical from a library (typically a fragment library).
building block in the experiment and generates a sound pulse that ejects 2.5 nL onto a M
crystallization plate is sealed by a plate lid (E) which contains small apertures (F) th
precipitant in the reservoir (H) governs the humidity of the plate before, during, and
chemicals are often added to the crystallization plate before the reservoir is ﬁlled (with n
residue (I). The plate is then sealed by the plate lid and equilibrated with the reservoir. P
screened chemical. Vapor diffusion drives co-crystallization (K) of the protein and each s
chemicals are added after the crystals have grown.
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ods were used to separately add protein and precipitant to 18 dis-
tinct locations in each of the 96 wells (1728 total experiments per
microplate). Acoustic transfers were made through apertures in
the crystallization plate lid, so that the crystallization plate was
equilibrated to the mother liquor before, during, and after the addi-
tion of all components (except for DMSO-solvated chemicals, which
were intentionally allowed to dry).
Soaking of proteins with a library of chemicals: Soaking experi-
ments were similar, but the library chemicals were separately
added to each of the 1728 locations on the MiTeGen plate after
the crystals had formed (Fig. 4B). In this strategy, crystals were
grown by vapor diffusion (by adding protein and precipitant to
the 1728 locations), and the library chemicals were added after-
wards. Each chemical was allowed to soak with the protein crystal
for 1 h before data collection. In soaking experiments, it was not
possible to prevent the DMSO from contacting the protein.
Consequently, soaking experiments used water to solvate the
chemicals in our mini-libraries instead of DMSO.
Each of the 96 crystallization wells in a MiTeGen in situ-1 crys-
tallization plate™ accommodated up to 18 co-crystallization or
soaking experiments; these 1728 distinct specimens (each contain-
ing similar protein crystals and a different chemical) were then
screened in situ using a plate handling system (le Maire et al.,
2011). A very high density of specimens could share a single crys-
tallization plate, making the experiment compact. The number of
distinct experiments that can be accommodated on one MiTeGen
plate is equivalent to 13½ Dewars, each fully loaded with 8 V1
uni-pucks. A very high rate of sustained data acquisition was pos-
sible, using the plate handling system to rapidly move between
specimen locations (see Section 2.5).crystallization microplate. The Echo 550 (A) uses sound energy to transfer micro-
A motorized transducer (B) moves under the source plate (C) to the location of each
iTeGen in situ-1 crystallization plate™ ((D), shown without plate lid for clarity). The
rough which each component is transferred to the crystallization region (G). The
after protein transfer. In a co-crystallization experiment, DMSO-solvated screened
o plate lid) and the DMSO is allowed to evaporate, leaving behind the dry chemical
rotein and precipitant (J) are added through the apertures and combined with each
creened chemical. Soaking experiments are prepared in a similar way, but screened
Fig. 4. Both co-crystallization and soaking strategies are possible for high throughput screening of high-density fragment libraries deposited on crystallization microplates
(thermolysin crystals are shown with eosin colorant). Co-crystallization: High throughput screening of protein crystals and a fragment library using co-crystallization (A) uses
ADE to deposit 2.5 nL of each DMSO-solvated chemical fragment at each distinct location on the crystallization plate (1728 locations per MiTeGen plate) (A1). Each DMSO-
solvated fragment is allowed to dry for 1 h. The crystallization plate is then sealed with a plate lid (Fig. 2) and equilibrated with the protein precipitant solution. ADE is then
used to add protein and precipitant, through apertures, on top of the dry residue from each fragment in the library (A2). Vapor diffusion drives co-crystallization of each
fragment and protein over 24 h (A3). In situ data collection is recorded from the crystals in each droplet. Soaking: High throughput screening of protein crystals and a fragment
library by soaking each fragment with a crystal (B) uses ADE to deposit protein and precipitant at each distinct location in a sealed crystallization plate that is equilibrated
with the protein precipitant (B1). Vapor diffusion drives crystallization over 24 h (B2). Each chemical fragment is then soaked into a different protein crystal for 1 h (B3) and
X-ray diffraction data is obtained from each crystal/fragment soak.
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ware (Labcyte Inc., Sunnyvale, CA) to operate the Echo 550 and dis-
pense liquids to 18 locations in each of the 96 crystallization wells
on a MiTeGen plate is available from our group on request. This
plate deﬁnition was made in two stages using Echo Array Maker.
First, an array deﬁnition was generated to access each of the 96
wells on the MiTeGen plate. Then, the software was used to further
partition each crystallization well into 3 rows by 6 columns of
accessible destination locations using 1000 lm grid spacing.
To demonstrate the Echo 550s capability to prepare specimens
in MiTeGen plates, we ﬁrst used conventional manual techniques
to verify reliable crystallization conditions for four test proteins
(lysozyme, thermolysin, trypsin, and thaumatin) using the conven-
tional hanging drop vapor diffusion method (Table 1). For each pro-
tein, the same crystallization conditions identiﬁed in the manual
experiments were found to be effective in the acoustically pre-
pared experiments (with the working volume reduced 100
0-fold). In our experiments the precipitant in the reservoir was
held in place by a 1% agarose solution (Whon et al., 2009).
Diffraction data were collected at the National Synchrotron
Light Source (NSLS) beamlines X12b and X25. Data sets were pro-
cessed with HKL2000 (Otwinowski and Minor, 2001) and further
processed using CTRUNCATE in the CCP4i suite (Winn et al.,
2011). Structures were obtained by molecular substitution from
published models and reﬁned using REFMAC (Winn et al., 2003)
and ArpWarp (Perrakis et al., 2001) (starting models
1lyz-lysozyme, 4tln-thermolysin, 4i8 g-trypsin, 1thi-thaumatin)
(Diamond, 1974; Holmes and Matthews, 1981; Liebschner et al.,
2013; Kim et al., 1988). Binding fragments were identiﬁed in a
Fobs  Fcalc omit difference map by visual inspection using coot
(Emsley and Cowtan, 2004).2.1. Using methylene blue to probe for cross-contamination
Compact specimen holders such as the high-density MiTeGen
microplates described here can accelerate applications such as
fragment screening. Our objective was to maximize the number
of specimens that can be discretely assembled on a MiTeGen plate
without cross-contamination between adjacent experiments.
However, as the density of specimens is increased there is the dan-
ger that adjacent experiments will become cross-contaminated. To
test the capability of the Echo 550 to accurately dispense building
blocks to 18 distinct locations in each MiTeGen crystallization well,
we alternately dispensed colored (methylene blue colorant) and
clear droplets to form a checkerboard pattern at nearly twice the
specimen density as we used in our experiments (32 locations
per well compared to 18 locations) (Fig. 5). The blue dye used in
this demonstration imparts a distinctive color even at 1% concen-
tration, so that even very limited cross-contamination could be
easily detected by visual inspection.
2.2. Screening a heavy-metal mini-library by soaking
In addition to preventing cross-contamination, compact
high-density formats for high throughput screening must reliably
deliver each screened chemical to the desired location. To verify
the ﬁdelity of our strategy for delivering screened chemicals, we
assembled a mini-library of 6 heavy-metals. The soaking strategy
(Fig. 4B) was used for this demonstration, so each heavy-metal
solution was added to already-grown thermolysin and trypsin
crystals. Excitation scans were then used to detect the presence
of each heavy atom by recording the ﬂuorescence peak at the
expected X-ray wavelength. The excitation scans were performed
Table 1
Crystallization conditions.
Lysozyme Trypsin Thermolysin Thaumatin
Protein 120 mg/mL 30 mg/mL + 10 mg/mL benzamidine 330 mg/mL + 45% DMSO 50 mg/mL
Buffer 0.1 M NaAc pH4.6 10 mM CaCl2 + 20 mM HEPES pH 7 50 mM tris pH 7.5 Distilled water
Precipitant 8% NaCl 40% PEG 8000 + 400 mM AmSO4 + 200 mM bis–tris 1.45 M CaCl2 1.5 M NaK tartrate + 0.1 M bis–tris propane pH 6.6
Fig. 5. Highly accurate droplet transfers prevent cross-contamination. A checkerboard pattern of highly concentrated blue dye (methylene blue) was alternated with a 50/50
mixture of water and DMSO (clear solvent). The methylene blue was solvated in water and dehydrated almost instantly (leaving the dark residue shown), while the DMSO-
containing drops remained hydrated (because DMSO is hygroscopic). The methylene blue is an intense pigment that is evident at low concentration (a 100-fold dilution of the
starting concentration is still blue and easy to see), so even a modest amount of cross-contamination should be evident. The ﬁeld of view shown here contains 32 equally
spaced droplets at moderate magniﬁcation. We carefully examined 12 similar ﬁelds under high magniﬁcation (a total of 384 distinct droplets). None of the examined ﬁelds
contained any evidence of cross-contamination. The largest positional error for all of the 384 droplets tested was less than half of the target distance between the droplets.
Given that the specimen density shown here is almost twice the specimen density that we used in our experiments, we conclude that the likelihood of cross-contamination
with our high throughput screening strategy is very small.
E. Teplitsky et al. / Journal of Structural Biology 191 (2015) 49–58 53using a G-rob plate-screening robot to discretely target each of the
18 separate crystal containing droplets that had been soaked with
six heavy-metal solutions. Each heavy-metal was soaked into the
crystals on three droplets in each of the six columns. This way,
the MiTeGen plate well contained three similar rows, each of
which contained the same sequence of heavy-metals.
2.3. Screening a mini-library for known lysozyme ligands
Lysozyme crystals were soaked and co-crystallized with a frag-
ment mini-library. Previous groups have described data collection
from one or several protein crystals that reside in a crystallization
microplate well and which share a similar chemical environment
(Axford et al., 2012). We obtained in situ data from 18 lysozyme
crystals residing in a crystallization microplate well, with each
crystal having a unique chemical environment (each drop con-
tained the same precipitant and protein, but a different screened
chemical). We used both co-crystallization and soaking approaches
to combine lysozyme crystals with an 18-chemical fragment
mini-library in a single well of a crystallization microplate (in total
this experiment occupied eight crystallization wells). We then sep-
arately obtained in situ data from each of the 18 different fragment
chemicals. Our fragment mini-library contained benzamidine
(Table 2) and N-acetyl glucosamine, which are known lysozyme
ligands. We searched for the known ligands by inspecting the elec-
tron density map.
2.4. Screening a high concentration library with thaumatin in situ
We determined micro-crystallization conditions that com-
monly yield exactly one protein crystal in each 25 nL thaumatin
vapor diffusion crystal growth screen (Table 1). We prepared a
mini-library of 36 safe laboratory chemicals at high concentration
(100–500 mM). Some of the mini-library chemicals were notsufﬁciently soluble to form 100 mM solutions; in these cases the
excess chemical remained as a suspended solid (this includes the
ascorbic acid solution which is further described in Section 3.4).
We then grew thaumatin crystals on the same material that is used
in MiTeGen plates. Some of the crystals were grown on conven-
tional MiTeGen in situ-1 plates (at a density of 18 distinct crystal-
lization droplets per crystallization well), and some of the crystals
were grown in a custom crystallization chamber that contains 36
distinct crystallization droplets per crystallization well (the cus-
tom crystallization chamber is compatible with conventional mag-
netic pins, similar to the sample mounting grid described in Cohen
et al., 2014; currently under patent review). Each crystallization
droplet (usually containing exactly one crystal) was then combined
with one chemical from the mini-library, and allowed to soak for
1 h (including solutions containing suspended solids). X-ray
diffraction data were then obtained from one crystal in each crys-
tallization droplet.
2.5. In situ screening and diffraction data collection
The G-rob plate screening system at NSLS X12b was a conve-
nient high throughput tool for screening chemical libraries at room
temperature in situ on crystallization plates. The system includes a
customizable interface for partitioning each MiTeGen crystal well
into N by M discreet targets of equal size (N and M are integers).
Using the CBASS data acquisition software (Skinner et al., 2006),
we could automatically move to each of the 18 locations on each
of the 96 crystallization wells in the MiTeGen plates. Each target
could also be automatically photographed with the in-line camera.
By pairing the automated data collection protocol with known
crystal locations, we tested automatic screening of 1728 experi-
ments. However, technical difﬁculties (see discussion) limited the
achieved autonomy to 18–36 specimens. Consequently, we used
the G-rob plate screening system only to screen the heavy metals
54 E. Teplitsky et al. / Journal of Structural Biology 191 (2015) 49–58(Section 2.2) and approximately 20% of the ligands (Section 2.4).
The remaining ligands were screened at room temperature in situ
at X25. The bromine binding to trypsin (protein data bank 4TPY)
and the ascorbic acid binding to thaumatin (protein data bank
4TVT) that we observed in our room-temperature experiments
(see Sections 3.2 and 3.4) were repeated at X25 with similarly pre-
pared specimens that were cryo-cooled (two last columns in
Table 2).
Because mechanical problems limited the automation potential
for the G-rob, we developed a strategy for obtaining in situ data at
NSLS X25 (a more powerful beamline). Since no plate handling sys-
tem is available at X25, we mechanically cut our MiTeGen plates
into plate pieces small enough to be secured onto a conventional
goniometer head (Soares et al., 2014). This yielded improved data
by matching the low mosaic spread of our room temperature crys-
tals with the fast readout speed of the Pilatus 6M detector at X25.
In this way, we could overcome the reduced signal that is available
from the low X-ray dose limits for room temperature crystals by
reducing the background noise using a ﬁne phi slicing strategy
(0.1) that exploited the low mosaicity (0.04) of our room tem-
perature crystals (Owen et al., 2014). Approximately 80% of the
electron density maps in this project were obtained from X25 using
plate pieces, or using the custom crystallization chamber men-
tioned in Section 2.4. Since lysozyme, trypsin, and thaumatin crys-
tals have similar diffraction limit (1.2 Å) and mosaicity (0.04),
we used a similar data collection strategy for all of these crystals
(0.1 rotation, 0.1 s exposure, 220 mm detector distance, 10
attenuation, 50 l beam). Although optimal data would have been
obtained from even smaller oscillations (1/2 mosaicity  0.02,
see Mueller et al., 2011), data collection time would have been
prohibitive.3. Results
Our strategy was to exploit the reduced mosaicity of room tem-
perature crystals to support a 0.1 ﬁne phi slicing data collection
strategy. In this way we compensated for the low dose-tolerance
of the room temperature crystals by using ﬁne phi slicing to reduceTable 2
Data collection and model reﬁnement statistics (dose was estimated using RADDOSE, see
Protein Lysozyme (RT) Thaum
Ligand Benzamidine (co-cr.) Benzamidine (soak) Ascor
Data collection statistics
X-ray source NSLS X25
Focus FWHM (lm) 360  70
Exposure time (s) 0.1
Attenuation 0.1
Wavelength (Å) 1.1 1.1 1.1
Detector dist. (mm) 220 220 220
Beam aperture (lm) 75  75 100  100 100 
Image width () 0.1 0.1 0.1
Data wedge () 100 100 100
Average dose (MGy) 0.11 0.11 0.10
Crystal quality statistics
Crystal size (mm) 100  100 100  100 120 
Reﬁned mosaicity () 0.03 0.05 0.05
Resolution (Å) 1.2 (26.8) 1.4 (44.0) 1.2 (5
Rsym (%) 4.5 (16.9) 5.8 (31.2) 3.4 (6
I/rI 66.19 (11.5) 34.03 (3.7) 36.3 (
Completeness (%) 100.0 (100.0) 98.0 (90.1) 69.3 (
Redundancy 17.3 5.3 6.8
Modeling and reﬁnement statistics
No. of reﬂections 34,003 22,042 52,77
Rwork/Rfree 22.9/25.1 14.7/17.9 14.7/1
RMS bond length (ÅA
0
) 0.029 0.028 0.031
RMS bond angles () 2.441 2.441 2.875the background noise. In favorable cases, the low mosaicity of
room temperature crystals yielded signal-to-noise ratios compara-
ble to those of cryo-cooled crystals.
3.1. Preventing cross-contamination
To ensure that the three-by-six specimen deposition density
would segregate the contents of adjacent experiments, we depos-
ited alternating clear droplets and droplets containing methylene
blue at a density of droplets that was almost double that used in
our experiments (32 versus 18 droplets per crystallization well).
A representative picture of a high-density ﬁeld is shown in Fig. 5.
Visual inspection of 12 equivalent high-density ﬁelds showed that
cross-contamination did not occur in any of the 384 repetitions.
The methylene blue dye used in this experiment is clearly visible
even at 1% concentration so we are conﬁdent that any
cross-contamination would have been evident by inspection.
3.2. Heavy-metal mini-library soaked into thermolysin and trypsin
crystals
As positive controls, we soaked six readily detectable
heavy-metal reagents with crystals of thermolysin and trypsin. A
picture of one row of six crystals that were soaked with six
heavy-metal reagents has been rotated by 90 for clarity (Fig. 6,
column 2). A close-up view of the crystals in the picture is also
shown (column 3). We used a G-rob plate-handling system to sep-
arately probe each of the 18 soaking experiments for the presence
of the expected heavy-atom. In all 18 cases we positively identiﬁed
the expected heavy-atom in each location by observing a ﬂuores-
cence peak at the appropriate wavelength for each heavy-atom
(Fig. 6, column 4). We also obtained room temperature X-ray
diffraction data from thermolysin and trypsin crystals that were
soaked with each of the six heavy-metal solutions. For each of
these twelve data sets (both proteins soaked with six metals each),
representative reﬂections with a common resolution of 2.3 Å
were picked from the last frame of the data collection sweep.
These reﬂections showed that the cumulative X-ray dose did notZeldin et al., 2013).
atin (RT) Trypsin (RT) Thaumatin (100 K) Trypsin (100 K)
bic acid Sodium bromide Ascorbic acid Sodium bromide
NSLS X12b NSLS X25
800  200 360  70
2.0 1.0
1.0 1.0
0.9198 1.1 0.9198
120 200 200
100 150  150 50  50 50  50
0.2 1.0 1.0
50 270 270
0.04 3.30 3.10
120 200  1000 100  100 150  700
0.06 0.37 0.43
4.0) 1.3 (44.0) 1.2 (54.0) 1.3 (44.0)
8.5) 8.1 (84.1) 2.9 (34.7) 6.4 (42.5)
1.0) 18.4 (0.8) 42.8 (1.0) 27.4 (1.1)
31.6) 73.5 (41.7) 89.9 (23.6) 90.4 (33.2)
7.5 14.6 10.6
3 38,989 68,461 44,900
7.7 14.9/18.4 14.6/16.2 14.2/17.2
0.023 0.034 0.025
2.236 2.941 2.361
Fig. 6. Excitation scans were used to conﬁrm that thermolysin crystals were successfully combined with six heavy-metal reagents. Column 1 contains the name of each
heavy-metal reagent and information about the sample reﬂection indicated in column 5 (index and signal-to-noise). Column 2 is a single picture of six thermolysin crystals
after soaking with the six heavy-metal reagents. Column 3 shows a magniﬁed view of each crystal (the insoluble platinum compound can be seen in the bottom row). Column
4 shows the excitation scan at the white line (wavelength shown) for each heavy atom. Column 5 is a magniﬁed view of a few reﬂections from the last frame of the data
collection sweep, with resolution near 2.3 Å (the orange arrow indicates the reﬂection described in column 1).
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signal-to-noise ratio for each reﬂection is shown in Fig. 6, column
1, along with a picture in column 5). The twelve thermolysin crys-
tals diffracted to an average resolution of 1.9 ± 0.1 Å with an aver-
age mosaicity of 0.09 ± 0.03 (data not shown). The twelve trypsin
crystals diffracted to an average resolution of 1.4 ± 0.2 Å with an
average mosaicity of 0.06 ± 0.02. Data collection and reﬁnement
statistics from the crystal where we ﬁrst observed bromine bound
to trypsin are shown in Table 2 (the other trypsin data sets that
were obtained at X12b were similar).
We used excitation scans to conﬁrm that trypsin crystals were
successfully combined with the same six heavy-metal reagents
that were used for thermolysin. All of the scans conﬁrmed the
presence of the desired heavy-atoms. We then obtained X-ray
diffraction data from each of the crystals. All of the crystals dif-
fracted to the typical resolution limit for trypsin. The data had
anomalous signals for three known trypsin binding heavy-atoms
(copper sulfate and the two cobalt salts had a strong anomalous
signal, nickel sulfate had a weak anomalous signal).
The X-ray diffraction data also revealed anomalous signal for
sodium bromide, a trypsin derivative that had not been previously
deposited in the PDB. The structure of this derivative was readily
solved [4TPY] using the anomalous diffraction from threehigh-occupancy bromine atoms (there are also lower occupancy
sites). The phasing power was of high quality. Fig. 7 shows the
experimental map (FobsUobs, contoured at 2.5r) superposed on
the ﬁnal atomic structure. The experimental map was generated
from the anomalous data using HKL2MAP after 20 cycles of solvent
ﬂattening (Supplemental Fig. 1) (Pape and Schneider, 2004).
3.3. In situ ligand screening: known lysozyme ligands
We used both co-crystallization and soaking approaches to
screen lysozyme crystals with a mini-library consisting of 18
chemicals (including the known ligands N-acetyl glucosamine
and benzamidine). For both approaches, the resulting electron den-
sity conﬁrmed that our library screening system had correctly
paired the lysozyme crystals with its N-acetyl glucosamine ligand
(data not shown) and with its benzamidine ligand (Fig. 8). None of
the other 16 screened chemicals was observed in the electron
density.
3.4. In situ fragment screening: novel thaumatin fragment hits
We soaked thaumatin crystals with a high-concentration
mini-library (chemical concentrations were between 100 mM
Fig. 7. We used excitation scans to conﬁrm that trypsin crystals were successfully
combined with the same six heavy-metal reagents that were used for thermolysin
(the thermolysin data are in Fig. 6). All of the scans conﬁrmed the presence of the
desired heavy atom. We then obtained X-ray diffraction data from each of the
crystals. All of the crystals diffracted to the typical resolution limit for trypsin. The
data had anomalous signal for three known trypsin binding heavy-atoms (copper
sulfate and the two cobalt salts had a strong anomalous signal, nickel sulfate had a
weak anomalous signal). The X-ray diffraction data also revealed anomalous signal
for sodium bromide, a trypsin derivative not previously deposited in the PDB. The
structure of this derivative was readily solved [4TPY] using the anomalous
diffraction from three bound bromine atoms. The phasing power was of high
quality. The experimental map (FobsUobs, contoured at 2.5r) is superposed on the
ﬁnal atomic structure. The experimental map was improved by 20 cycles of solvent
ﬂattening.
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arate crystals in each crystallization chamber, each soaked for 1 h
with a different high concentration chemical from our
mini-library. Using this strategy, we demonstrated that L-ascorbic
acid binds to ﬁve locations on thaumatin. In situ data from thau-
matin crystals soaked in 500 mM ascorbic acid revealed binding
sites that were arranged into two clusters (Fig. 9). The ascorbic acid
molecules in each cluster interacted with each other either directly
(Panel B) or via bridging water molecules (Panel A).4. Discussion
High throughput strategies that use X-ray diffraction to screen
chemical libraries will beneﬁt from improvements in technologyFig. 8. In situ data collection identiﬁes known lysozyme ligands from a fragment mini-lib
our co-crystallization and soaking approaches for high throughput in situ screening. The o
for benzamidine (shown above) revealed the known ligands (electron density contoured
strategy (panel B). For this experiment, we obtained in situ data from 18 protein crysta
chemical at a concentration of 100 mM).that make better use of resources. We outline a strategy that uses
acoustic specimen preparation with the Echo 550 to assemble
1728 distinct experiments on a MiTeGen microplate. Our strategy
optimizes the use of resources such as space (1728 chemicals
screened in one microplate), consumables (2.5 nL of protein, pre-
cipitant, and the screened chemical) and time (2.33 specimens pre-
pared per second). By using the automated computer-controlled
data collection strategy outlined in Section 2.5, our method also
makes optimal use of synchrotron X-ray diffraction end stations
which are limited in availability, and greatly minimizes the
demand for scientiﬁc staff to supervise the data collection.
Coupled with the brightness of 4th generation synchrotron sources
such as NSLS II, our strategy will deliver unprecedented rates of
data acquisition and a commensurately enhanced ability to screen
large chemical libraries.
The most powerful high throughput screening capability of our
system came from the integration of high throughput capabilities
of the Echo 550 liquid handler and the G-rob plate-handling sys-
tem. The combination of target location functionality of a liquid
handler and automated plate handling system (which knows
where to ﬁnd each of the 1728 experiments) with the data collec-
tion software (which can obtain X-ray data under automated com-
puter control), makes it possible to screen chemical libraries with
an unprecedented level of automation. Since each crystal data set
required about 20 min, the 1728 experiments in each MiTeGen
microplate could hypothetically give this system an operational
autonomy of 24 days. In practice, mechanical limitations restricted
the achievable autonomy to just one or a fewwells before the accu-
mulation of target positioning errors caused the X-ray beam to
begin missing the specimen. In part, these target positioning errors
derive from a slight angular misalignment of the gripped plate (in
one experiment, we measured a systematic 0.4 misalignment, so
that each consecutive 9 mm well contributed 80 microns of error).
Other factors may also contribute to random or systematic errors.
Simple software improvements (such as coupling a short ‘‘grid
scan’’ X-ray search protocol to a feedback loop) should prevent
the buildup of positioning errors and allow fully automated screen-
ing of all 1728 experiments. Simple arithmetic demonstrates that
this technology will allow the plate handling system at NSLS II to
sustain a very high rate of data acquisition in high throughput
screening applications.
Screening large fragment libraries for structure-based drug
discovery projects will likely remain the most challenging mis-
sion for this type of high throughput screening. Libraries of this
type can contain thousands of fragments. For these projects, we
anticipate that our system will support a throughput rate for
fragment screening that is greater than 1 data set per second.
It can be challenging to obtain highly complete data from a sin-
gle in situ crystal, so two or more data sets may be merged fromrary. We used a fragment mini-library with two known ligands of lysozyme to test
mit difference electron density map for N-acetyl glucosamine (data not shown) and
at 3r) using both the crystal soaking strategy (panel A) and the co-crystallization
ls that reside in each microplate well (each crystal was combined with a different
Fig. 9. In situ data collection identiﬁes novel thaumatin ligands from a high-concentration fragment mini-library. High throughput screening using ADE reduces the use of
protein and chemicals (2.5 nL used per screen), reduces the specimen preparation time (2.33 per second), reduces the consumption of labware (1728 screens per MiTeGen
crystallization plate), and efﬁciently uses available synchrotron time (less down time for robotic specimen exchange). This efﬁcient use of resources simpliﬁes fragment
screening using a ‘‘one at a time’’ strategy (without pooling different fragments into cocktails) at high concentrations (>100 mM) without the danger that a high aggregate
chemical concentration may disrupt the integrity of the protein crystals. By screening a high concentration mini-library (500 mM) we identiﬁed multiple thaumatin binding
sites for ascorbic acid [4TVT] (difference omit map shown in green). The binding sites were arranged into two clusters. The ﬁrst cluster binds three ascorbic acid molecules
(with end-to-end geometry) between two thaumatin proteins in adjacent asymmetric units (Panel A, contoured at I/rI = 3.0). The second cluster binds two ascorbic acid
molecules (with stacked ring geometry) in a cleft between the alpha-helical and beta-sheet domains of thaumatin (Panel B, contoured at I/rI = 2.0). By facilitating the
simultaneous observation of multiple copies of the same fragment (or of different fragments), this high-concentration strategy could elucidate ligand–ligand interactions (in
addition to ligand–protein interactions). Information about ligand–ligand interactions might simplify the construction of tightly binding therapeutic compounds.
E. Teplitsky et al. / Journal of Structural Biology 191 (2015) 49–58 57different crystals containing the same fragment (in some cases
this may not be needed because fragment screening does not
require high completeness, e.g. 71% in le Maire et al., 2011).
For example, in the case of the NSLS II beamline AMX (which
will be used to screen low mosaicity room temperature crystals),
the maximum throughput speed will be limited by the detector
readout rate (and not by the brilliance of the X-ray facility). For
this example, if we optimistically project the medium term
detector development outlook to a readout rate of 500 frames
per second, then 0.1 data wedges will sample 50 of reciprocal
space per second. This is approximately equal to the angular
data acquisition limit for most in situ crystallization plates
(including the MiTeGen plate; Soliman et al., 2011), so the
screening throughput rate will be approximately one screened
fragment per second. This is approximately equal to the time
needed for a cryo-cooled 20 lm crystal to absorb an X-ray dose
equal to the Henderson limit (D1/4 = 107 Gy, Henderson, 1990) at
the AMX beamline (ﬂux 1013 ph/s; Hodgson et al., 2009). At
room temperature, the dose limit will be reduced by about
50-fold, so the X-ray beam will have to be attenuated in order
to obtain a full data set from one crystal (unless much faster
detectors become available). The crystal screening rate would
still be limited by the detector speed and would remain approx-
imately 1 screened chemical per second. Alternatively, the dose
from the un-attenuated beam could be distributed by merging
data from many crystals that all contain the same fragment.
The speed and ﬂexibility of acoustic in situ high throughput
screening will continue to advance with ongoing developments
in robotic hardware, control software, and crystallization labware.
We previously discussed the need to compensate for minor robotic
drift and the potential to leverage advances in detector technology.
Software could be back-integrated with the specimen preparation
database and forward-integrated with tools for data collection,
processing, and ligand search (Delagenière et al., 2011). Software
support should also be expanded to other plate designs, such as
the Crystal Direct™ plates. Crystal Direct™ plates have a very large
crystallization shelf (we have accommodated 2016 specimens onone plate), and with the support of laser assisted crystal mounting
systems (Cipriani et al., 2012) it should be possible to extend
acoustic in situ technology to cryogenic specimens. New labware
could also increase compatibility with beamlines that lack plate
handling robots (Cohen et al., 2014). These improvements to
acoustic in situ high throughput screening will continue to
strengthen structure-based drug discovery as a mainstream tool
to improve human health.
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